Roland G.
- Country
- Germany
- Department
- Neurosurgery
Research Overview
- ONC201 for the Treatment of Newly Diagnosed H3 K27M-mutant Diffuse Glioma Following Completion of Radiotherapy: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study (The ACTION Study)
- Evaluation of Perampanel Efficacy in Pre-Surgical Treatment of Patients with Progressive Glioblastoma: A Controlled Study
- Evaluation of SonoCloud-9 with Carboplatin Versus Lomustine or Temozolomide in First Recurrence Glioblastoma Post-Resection: A Randomized, Open-Label Trial
Data & Insights
Has run more than one trial at 29 of 69 partner sites.
Specializations
Neuro-Oncology
Specializes in advanced treatment approaches for glioblastoma and various grades of gliomas, with particular focus on innovative therapeutic strategies for both newly diagnosed and recurrent cases.
- Progressive Glioblastoma Management
- Grade 2 and 3 Glioma Treatment
- H3 K27M-mutant Diffuse Glioma
Investigates novel therapeutic approaches including radioimmunotherapy and targeted molecular treatments.
Neurovascular Medicine
Focuses on treating aneurysmal subarachnoid hemorrhage with emphasis on exploring anti-inflammatory interventions to improve patient outcomes.
- Inflammatory Response Management
- Post-hemorrhagic Treatment
- Neurological Recovery
Explores innovative therapeutic strategies in acute cerebrovascular conditions.
Experimental Therapeutics
Investigates cutting-edge treatment modalities including blood-brain barrier modulation and novel drug delivery systems for brain tumors.
- Targeted Drug Delivery
- Chemotherapy Enhancement
- Immunotherapy Applications
Develops personalized treatment approaches for complex neurological conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.